- Anal neoplasia is a category of diseases referring to tumors that develop in anal tissue, and it can include both benign and malignant tumors.
- High-risk HPV infection is one of the most important related factors, and immunosuppression, smoking, multiple sexual partners, anal intercourse, and a history of vulvar, vaginal, or cervical cancer may be associated with the risk.
- Fundamentally, it is a process in which abnormal cells proliferate without control and may invade surrounding tissues or spread to other areas.
- Representative symptoms may include anal or rectal bleeding, a mass around the anus, pain or pressure, itching, discharge, and changes in bowel habits.
- Risk can vary from person to person depending on the HPV type and whether the infection is persistent, immune status, smoking, history of related cancers, and patterns of sexual exposure.
- Symptoms may be distinct, such as bleeding or pain, or may appear as a mass, itching, discharge, or fecal incontinence; therefore, the scope or progression of the disease cannot be determined by symptoms alone.
- Diagnosis combines verification of medical history and symptoms with digital rectal examination, anoscopy, high-resolution anoscopy, proctoscopy, or ultrasound evaluation, and is confirmed by biopsy if necessary.
- Since bleeding or lumps can occur in various anal and rectal diseases, cancer is not confirmed solely based on examination findings or abnormal screening results; biopsy interpretation is required if necessary.
- Management involves jointly evaluating the extent and progression of the disease, overall health status, and patient preferences to adjust diagnostic confirmation, treatment selection, risk factor management, and follow-up.
- Currently mentioned treatment methods include radiotherapy, chemotherapy, and surgery; the choice of method depends on the stage, health status, and patient preference.